MiMedx - MDXG Quarterly Revenue Growth

MiMedx (MDXG) - corporate logo

Quarterly revenue growth dynamics demonstrate the scaling pace of MiMedx Group, Inc. (MDXG), where the value of -45.10 reflects the metric's balance. Profitability relies on EpiFix sales and Medicare coverage coupled with high margins. The strategy is based on creating regenerative membranes for surgery. Strong patent protection and physician recognition ensure the company's leadership in the tissue healing biomaterials segment.

MDXG MiMedx Group Quarterly Sales Growth Rate (07/04/2022 - 11/20/2026)

MDXG (MiMedx): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental company analysis:MDXG - mimedx.com
Mass-produced product of mimedx.com

Quarterly sales growth measures the rate of change in operating income, allowing investors to differentiate sustainable development from random price spikes. By analyzing the percentage change in quarterly revenue, one can assess the commercial success of MiMedx Group, Inc. (MDXG) in implementing regenerative biomaterials into surgery and wound care, which is critical for confirming the market value of the portfolio assets.

Competitor analysis

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Akero Corp|Metsera Therapeutics (MTSR) - Quarterly Sales Growth Rate|Revenue Growth QoQ moonlaketx.com (MLTX)|Quarterly Sales Growth Crinetics Pharmaceuticals CRNX|Revenue Growth QoQ NewAmsterdam Pharma N.V. NAMS|Quarterly Sales Growth Rate Soleno Therapeutics Inc (SLNO)|FOLD - Revenue Growth QoQ|ETNB: Revenue Growth QoQ|AGIO: Quarterly Revenue Growth|Structure Therapeutics Inc. - Quarterly Revenue Increase|Revenue Growth QoQ Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate